| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |